| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |